BlackRock Capital Allocation Term Trust (NYSE:BCAT) Sets New 52-Week High at $16.39

Shares of BlackRock Capital Allocation Term Trust (NYSE:BCAT) reached a new 52-week high on Tuesday . The stock traded as high as $16.39 and last traded at $16.39, with a volume of 87877 shares traded. The stock had previously closed at $16.32.

BlackRock Capital Allocation Term Trust Trading Up 2.0 %

The firm has a fifty day simple moving average of $15.60 and a 200-day simple moving average of $14.94.

BlackRock Capital Allocation Term Trust Dividend Announcement

The company also recently declared a monthly dividend, which will be paid on Thursday, March 28th. Stockholders of record on Friday, March 15th will be paid a dividend of $0.127 per share. This represents a $1.52 annualized dividend and a dividend yield of 9.15%. The ex-dividend date of this dividend is Thursday, March 14th.

Insider Buying and Selling

In other BlackRock Capital Allocation Term Trust news, major shareholder Saba Capital Management, L.P. acquired 8,476 shares of the business’s stock in a transaction that occurred on Monday, February 5th. The shares were acquired at an average cost of $15.40 per share, for a total transaction of $130,530.40. Following the completion of the acquisition, the insider now directly owns 14,476,448 shares of the company’s stock, valued at approximately $222,937,299.20. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders bought a total of 1,902,871 shares of company stock worth $29,673,698 over the last three months.

Hedge Funds Weigh In On BlackRock Capital Allocation Term Trust

Several hedge funds have recently added to or reduced their stakes in BCAT. Advisor Resource Council acquired a new position in shares of BlackRock Capital Allocation Term Trust during the 4th quarter worth about $1,564,000. Raymond James Financial Services Advisors Inc. boosted its stake in BlackRock Capital Allocation Term Trust by 6.8% during the 3rd quarter. Raymond James Financial Services Advisors Inc. now owns 25,074 shares of the company’s stock worth $363,000 after acquiring an additional 1,589 shares during the last quarter. Cambridge Investment Research Advisors Inc. increased its stake in BlackRock Capital Allocation Term Trust by 6.0% in the third quarter. Cambridge Investment Research Advisors Inc. now owns 128,956 shares of the company’s stock valued at $1,869,000 after purchasing an additional 7,272 shares in the last quarter. Advisor Partners II LLC bought a new stake in BlackRock Capital Allocation Term Trust in the third quarter valued at approximately $7,966,000. Finally, Saba Capital Management L.P. boosted its position in shares of BlackRock Capital Allocation Term Trust by 17.2% during the third quarter. Saba Capital Management L.P. now owns 10,259,217 shares of the company’s stock worth $148,656,000 after purchasing an additional 1,507,756 shares in the last quarter. Institutional investors and hedge funds own 36.12% of the company’s stock.

About BlackRock Capital Allocation Term Trust

–